In this session, Dr. Lisa Saiman will address the challenges of infections in people with CF and discuss why infections remain a major focus of the CF community, even in the era of effective CFTR modulators. She will provide an overview of CF infections, describe ongoing studies to increase our understanding of CF microorganisms and their optimal treatment, and discuss current strategies to develop new anti-infective agents to treat even the most difficult infections.
Identify ongoing challenges in the treatment of infections in people with CF, including the potential impact of CFTR modulators on infections.
Describe ongoing studies to improve our understanding of CF microorganisms including detection, diagnosis and optimal treatment.
Discuss strategies to develop new anti-infective therapies to treat people with CF.